BridgeBio Pharma Inc.

NASDAQ: BBIO · Real-Time Price · USD
51.30
0.12 (0.23%)
At close: Aug 15, 2025, 3:59 PM
51.00
-0.58%
After-hours: Aug 15, 2025, 07:58 PM EDT

BridgeBio Pharma Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-543.35M -643.2M -484.65M -586.45M
Depreciation & Amortization
6.08M 6.49M 6.77M 5.84M
Stock-Based Compensation
95.8M n/a 91.56M 99.5M
Other Working Capital
33.5M -13.05M 28.43M -7.23M
Other Non-Cash Items
-79.25M 103.93M -61.25M 18.5M
Deferred Income Tax
n/a n/a n/a -30.93M
Change in Working Capital
32.04M 5.06M 28.08M -4.4M
Operating Cash Flow
-520.73M -527.72M -419.49M -497.93M
Capital Expenditures
-933K -1.31M -6.32M -48.25M
Cash Acquisitions
-140K n/a 120M -35M
Purchase of Investments
-88.4M -137.26M -193.06M -643.27M
Sales Maturities Of Investments
158.23M 193.11M 532.52M 477.04M
Other Investing Acitivies
-7.97M -503K 120M 48.65M
Investing Cash Flow
60.78M 54.03M 453.15M -200.83M
Debt Repayment
476.58M n/a -20.49M 1.08B
Common Stock Repurchased
-7.53M -6.88M -1.56M -204.75M
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-35.34M 8.61M 4.06M -138.49M
Financial Cash Flow
748.46M 451.54M -13.13M 736.45M
Net Cash Flow
288.51M -22.15M 20.52M 37.69M
Free Cash Flow
-521.66M -529.03M -425.81M -546.18M